Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,580.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,302.0,1.0,=,1.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1454.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,187.0,1.0,=,7.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1582.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,685.0,1.0,=,2.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2180.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,545.0,1.0,=,4.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2340.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,299.0,1.0,=,7.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2881.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,1349.0,1.0,=,2.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3943.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,2621.0,1.0,=,1.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,608.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,206.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,625.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,335.0,1.0,=,1.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,893.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,345.0,1.0,=,2.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,912.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,307.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1177.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,375.0,1.0,=,3.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1190.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,545.0,1.0,=,2.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1309.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,387.0,1.0,=,3.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1357.0,1.0,Gamma,18,L18F + T20N + P26S + D138Y + R190S + K417T + E484K + N501Y + H655Y + T1027I + V1176F,1,=,543.0,1.0,=,2.5